M Gittelman - Organization science, 2007 - pubsonline.informs.org
… firm employees in broader knowledge-based communities. This paper analyzes biotechnology firms … research and proposes that the geography of their collaborations should reflect the …
MS Gertler, YM Levitte - Industry and innovation, 2005 - Taylor & Francis
… A large body of research suggests that the geographical distribution of VC available for biotechfirms is also highly concentrated. Cortright and Mayer (Citation2002) report that since …
… , in this paper we develop a trail of geographic linkages between scientists and firms in … the relationship between the locations of a biotechnologyfirm and a university scientist will be …
… in terms of opportunities, cost and risks. Our study investigates the knowledge spillover … of biotechfirms by means of inter- organizational citation patterns based on USPTO biotech …
A Phene, K Fladmoe‐Lindquist… - Strategic management …, 2006 - Wiley Online Library
… We use patent citation data from US biotechnologyfirms to test our hypotheses, and find that technologically distant knowledge contributes to breakthrough innovations only if it …
DB Audretsch - Small Business Economics, 2001 - Springer
… More specifically, they find that firms are likely to locate in geographic areas where scientists who have published articles on gene sequencing are located. The early evolution of the …
P Cooke - European Planning Studies, 2004 - Taylor & Francis
… , particularly those deriving from biotechnology, compared to the rapid rise in that precise capability on the part of networks of small, dedicated biotechnologyfirms (DBFs). This was …
M Fontes - Regional development in the knowledge economy, 2006 - api.taylorfrancis.com
… by new biotechnologyfirms (NBFs), located outside major concentrations of biotechnology … questions concerning the potential role of these firms–which are found to be extensively …
A Rosiello - European Planning Studies, 2007 - Taylor & Francis
… World-wide, thousands of dedicated biotechnologyfirms (DBFs) have been created in proximity to PROs and they employ genetic information to produce new drugs and diagnostic tools…